Oculis Holding AG Ordinary shares (OCS)

Oculis Holding AG Ordinary shares (OCS) is listed on Nasdaq, where it has traded since March 3, 2023.

Listed On
Nasdaq
Listed Since
March 3, 2023
Employees
67
Market Cap
$491M

About Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 59 institutions reported holding OCS, with 23.2 million shares worth $322.0 million in aggregate. The largest reported holder was Eqt Fund Management S.a R.L, with 7.0 million shares worth $96.4 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.

InstitutionSharesValueQuarter change
Eqt Fund Management S.a R.L6,950,294$96MAdded 17.8%
Aberdeen Group2,159,809$30MAdded 23.63%
Millennium Management2,042,467$28MAdded 123.7%
Pivotal Bioventure Partners Investment Advisor1,506,250$21MReduced 10.36%
Citadel Advisors987,204$14MAdded 512.09%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is OCS?

Oculis Holding AG Ordinary shares (OCS) is listed on Nasdaq, where it has traded since March 3, 2023.

Who are the largest institutional holders of OCS?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of OCS were Eqt Fund Management S.a R.L, Aberdeen Group and Millennium Management.

How many institutions own OCS?

59 institutions reported a position in OCS for the quarter ended June 30, 2026, worth $322.0 million in total.

Did institutions buy or sell OCS last quarter?

Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for OCS.

Every reported institutional holder, plus insider and congressional trades in OCS, on SentiSense.